April 11, 2022 -- PerkinElmer announced it is expanding its in vivo imaging portfolio with the launch of the Vega imaging system. The company said it will demonstrate Vega at the American Association of Cancer Research (AACR) Annual Meeting held April 8-13 in New Orleans.
Vega eliminates challenges associated with conventional handheld ultrasound systems, PerkinElmer said. The company gained the Vega technology with the acquisition of SonoVol.
The Vega ultrasound platform comes with two automated transducers and does not require a sonographer. Key features include brightness and motion modes, acoustic angiography mode for visualization of microvasculature, and shear wave elastography mode to measure and evaluate tissue stiffness.
Vega's widefield imaging enables researchers to visualize the pathophysiology of diseases such as cancer, liver and kidney disease, and cardio diseases, Perkin Elmer said.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
